Related Experiment Video
Updated: May 27, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Rare variants, common markers: synthetic association and beyond
1Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX 78245-0549, USA. jkent@txbiomedgenetics.org
Synthetic association, where common genetic variants tag rare ones, occurs but may not be frequent enough for reliable disease risk prediction. Careful analysis within population groups is key to discovering rare variants linked to disease.
Area of Science:
- Genetics
- Bioinformatics
- Population Genetics
Background:
- Synthetic association proposes that common genetic variants can tag functional rare variants.
- This phenomenon could enable indirect detection of rare variants influencing traits or diseases.
- Investigating this link is crucial for understanding genetic contributions to complex diseases.
Purpose of the Study:
- To investigate the occurrence and utility of synthetic association between common and rare genetic variants.
- To explore methods for detecting genetic associations using both common and rare variants.
- To identify conditions under which synthetic association is more pronounced.
Main Methods:
- Analysis of human exome sequence data from the 1000 Genomes Project.
- Examination of stochastic coupling between rare and common variants.
- Evaluation of association detection methods for combined variant types.
Main Results:
- Stochastic coupling between rare and common variants was confirmed.
- The frequency of this coupling may not be sufficient for common variants to reliably tag rare variants for disease risk prediction.
- Synthetic association signals were more apparent within specific population strata (ancestral or familial).
Conclusions:
- Synthetic association is a real phenomenon but may have limited practical application for general disease risk prediction due to insufficient frequency.
- Identifying rare variants contributing to disease risk may depend on analyzing specific population subgroups.
- The choice of analytical unit (e.g., gene, gene network) is critical for discovering the role of rare variants.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Principles of Pharmacogenetics: Types of Genetic Variants
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenomics: Identification of New Drug Targets

